TRIPS'le Nereye?: İlaç Sektörü Örneğinde Bir Değerlendirme

Sibel Çaşkurlu ()

Ekonomik Yaklasim, 2005, vol. 16, issue 55, 107-123

Date: 2005
Note: [English Title] Not available [English Abstract] TRIPS Agreement was a matter of bitter conflict between developed and developing countries during Uruguay Round Multilateral Negotiations. Although both sides compromised in the end, the concerns on the effects of the Agreement on developing countries are still maintained. On January 1, 2005 Indian parliament approved and passed the new Patents Act designed to make the necessary changes in its legislation to comply with its obligations under TRIPS Agreement. As one of the leading generic drugs exporter, India 's new Patents Act revived the discussion; whether under TRIPS provisions developing countries may reach essential drugs with affordable prices thereafter. In this paper the effects of TRIPS Agreement on developing countries are discussed by analysing pharmaceutical sector as an example. [English Keywords] Not available
References: Add references at CitEc
Citations:

Downloads: (external link)
http://dx.doi.org/10.5455/ey.10523 (application/pdf)
No restriction for articles.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eyd:eyjrnl:v:16:y:2005:i:55:p:107-123

Access Statistics for this article

Ekonomik Yaklasim is currently edited by Ozan Eruygur

More articles in Ekonomik Yaklasim from Ekonomik Yaklasim Association
Bibliographic data for series maintained by Ozan Eruygur ().